Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab for the Treatment of Soft Tissue Sarcoma

3rd Orphan Drug designation for Toripalimab

SHANGHAI, China, Sept. 17, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the U.S. Food and Drug Administration (FDA) …

Read More

Fresche Announces Expansion to its Automated Solutions that Accelerate IBM i (AS/400) Application Transformation to Modern Languages

Fresche broadens scope and adaptability of automated solutions to now transform RPG to PHP, producing high quality modern and scalable applications.

MONTREAL, Sept. 17, 2020 (GLOBE NEWSWIRE) — Fresche Solutions today introduced new capabilities with its automated solutions to accelerate application transformation of RPG applications …

Read More